FHI FEDERATED HERMES, INC. Insider Trading

CEO Saker Anwar Nusseibeh sells 8,950 shares of FHI at $57.34, reducing holdings 5.6% to 151.3K shares

Saker Anwar Nusseibeh, CEO of Federated Hermes Limited, sold 8,950 shares at $57.34 on 2026-06-08 in an open-market transaction, reducing his holdings from 160.2K to 151.3K shares. At the current price of $57.64, the stock has appreciated 3.0% over the past 30 days and 1.5% over 90 days, trading -2.4% from its 52-week high of $59.05. Looking at his same-ticker history at FHI, prior sells on 2025-11-03 each saw the stock gain +5.6% and +3.9% respectively over the following 30 days, with neither sale preceding a decline over 90 days. His cross-ticker track record shows 3 prior open-market sells with an average 90-day return of +10.3% and a well-timed rate of 0.00%, indicating those sales consistently preceded stock appreciation rather than declines. The transaction occurs against a backdrop of solid fundamentals: FHI posted revenue of $479.0M in the latest quarter, net income of $96.4M, annual revenue growth of +10.3%, and a P/E of 11.24.

VP Uhlman sells 72.4K shares at blended $56.23 (2 transactions), reducing stake by 21.5% to 264.0K shares.

Paul A Uhlman, Vice President at Federated Hermes, executed two separate sales on 2026-03-12, selling 62,105 shares at $56.15 and 10,287 shares at $56.72, for a combined $4,070,754.89 and blended average price of $56.23. This sale reduced his holdings from 336.4K shares to 264.0K shares, a 21.5% reduction of his pre-transaction position. At his same ticker (FHI), Uhlman's prior sales show mixed timing outcomes: 2 of 4 measurable prior sales were well-timed at the 90-day mark, with the most recent prior FHI sales on 2025-03-04 followed by 90-day returns of +12.3% and +10.8% (poorly timed), while 2024 sales showed negative 90-day returns (well-timed). The current stock price of $56.60 is near the 52-week high of $57.20 (-1.0%), and the 30-day and 90-day price moves are positive (+2.1% and +8.6% respectively), placing this sale in an elevated valuation context relative to the insider's historical trading window.

CFO Thomas R Donahue sells 30,000 FHI shares at $57.10; retains 591,492 shares post-transaction

Thomas R Donahue, VP CFO & Treasurer, sold 30,000 shares at $57.10 for $1,713,087.00 on 2026-03-13, reducing his stake from 621,492 to 591,492 shares. The sale occurred near the 52-week high of $57.20, with the stock currently trading at $56.60 and up 8.6% over the past 90 days. Donahue retains substantial holdings of 591,492 shares post-transaction, representing continued material ownership alignment with shareholders. The sale size of 30,000 shares constitutes a 4.8% reduction from pre-transaction holdings, a moderate adjustment in absolute terms. FHI exhibits solid fundamentals with a 10.3% annual revenue growth rate, $469.4M in latest quarterly revenue, and a P/E of 11.03, providing context that this sale does not occur in an operationally distressed environment.

VP Uhlman sells 11,739 FHI shares at $56.53; stock near 52-week highs, fundamentals strong at P/E 10.89.

Vice President Paul A. Uhlman sold 11,739 shares at $56.53 on 2026-03-05, reducing his holdings from 348,118 to 336,379 shares (a -3.4% reduction). The sale occurred near the 52-week high of $57.20, with the stock currently trading at $55.86 and up 5.1% over 30 days and 9.8% over 90 days. Federated Hermes posted strong fundamentals with $469.4M in quarterly revenue, $104.1M in net income, and 10.3% annual revenue growth; the company's P/E of 10.89 is modest relative to those earnings metrics. Uhlman's prior trades at FHI show poor 90-day timing (0 of 2 prior sells had negative post-sale returns, meaning the stock rose after each sale), suggesting historical difficulty in catching downturns at this ticker, though the most recent prior sales in March 2025 occurred near similar cyclical points and also preceded gains of 5.1% and 3.7% respectively over 30 days.

CEO Nusseibeh Saker Anwar sold 15,000 shares at blended average $48.54 on 2025-11-03; post-transaction holdings 157,039 shares.

CEO Nusseibeh Saker Anwar executed two separate sales totaling 15,000 shares (an 8.7% reduction in holdings) at an average price of $48.54, slightly below the current price of $49.06. The stock has declined 5.2% over 30 days and 4.6% over 90 days from the transaction date. At FHI specifically, his two prior open-market sales both showed negative 90-day returns (-7.4% and -6.2%), establishing a 100% well-timed rate on prior trades at this ticker. The company shows modest fundamentals with annual revenue growth of just 1.4% and a P/E of 15.19, suggesting a mature profile. While this sale reduced his equity stake, the timing pattern in his FHI history and the current price weakness warrant attention to whether this reflects informed positioning ahead of near-term headwinds.

VP Paul A Uhlman sold 13,474 shares at $37.59 avg, retaining 323.0K shares post-sale at FHI.

Paul A Uhlman, Vice President at Federated Hermes, executed 2 separate sales totaling 13,474 shares (13.5K shares) for $506,458.27 ($506.5K) at a blended average price of $37.59 on 2025-03-04. The sales represent a -4.0% reduction in his pre-transaction holdings of 336,461 shares (336.5K shares), leaving him with 322,987 shares (323.0K shares) after the transaction. The current price of $38.97 sits 10.0% below the 52-week high of $43.31, and the stock has declined 8.9% over the past 90 days. Uhlman's track record shows 2 prior open-market sells across all tickers; at FHI specifically, he completed sells on 2024-03-05 and 2024-02-07, though outcome measurement for those trades is not yet available. The company's fundamentals show a P/E of 12.07 with recent quarterly revenue of $408,456,000.00 ($408.5M) and net income of $87,538,000.00 ($87.5M), reflecting modest annual revenue growth of +1.4%.

CLO Germain Peter J sold 14,491 shares of FHI at $41.12 for $595,896.00; holds 198,153 shares post-sale.

Germain Peter J, EVP, CLO & Secretary, sold 14,491 shares (14.5K shares) at $41.12 on 2024-11-08 for a total value of $595,896.00, reducing his holdings by 6.8% to 198,153 shares. At the time of sale, the stock was trading within its 52-week range and near its 52-week high of $42.20. The company reported strong recent fundamentals with annual revenue growth of +11.3% and a P/E of 12.34. The sale represents a routine, modest reduction of executive holdings in a company with solid operational performance and appears to be a discrete portfolio adjustment rather than a signal of material concern.

VP John B Fisher sold 79,830 shares of FHI at $32.71 for $2.6M, reducing holdings from 522.4K to 442.6K (-15.3%)

John B Fisher, Vice President of Federated Hermes, executed a substantial sale of 79,830 shares at $32.71 on 2024-08-05, reducing his holdings by 15.3% to 442,570 shares post-transaction. The transaction occurred against a backdrop of mixed near-term price momentum: the stock is -11.7% from its 52-week high of $36.79, yet posted a modest +1.3% gain over the past 90 days, suggesting some recovery from previous weakness. The company's fundamentals remain stable with annual revenue growth of +11.3%, a P/E of 9.56, and net income of $21,027,000.00 in the latest quarter, providing no obvious operational red flags. The sale represents a material reduction in a senior officer's equity stake at a price neither at cyclical extremes nor at apparent distress levels.